Enzo Biochem (ENZ)
(Delayed Data from NYSE)
$1.12 USD
-0.04 (-3.45%)
Updated Sep 24, 2024 04:00 PM ET
After-Market: $1.13 +0.01 (0.89%) 7:58 PM ET
NA Value
NA Growth NA Momentum NA VGMBrokerage Reports
0 items in cart
Enzo Biochem, Inc. [ENZ]
Reports for Purchase
Showing records 1 - 20 ( 55 total )
Company: Enzo Biochem, Inc.
Industry: Medical - Biomedical and Genetics
ValuEngine Detailed Valuation Report for ENZ
Provider: ValuEngine, Inc
Company: Enzo Biochem, Inc.
Industry: Medical - Biomedical and Genetics
Termination of Coverage -Analyst(s) Departure
Provider: DAWSON JAMES SECURITIES, INC.
Company: Enzo Biochem, Inc.
Industry: Medical - Biomedical and Genetics
Analyst(s) Departure/Pending Change of Analyst
Provider: DAWSON JAMES SECURITIES, INC.
Analyst: GRISEWOOD S
Company: Enzo Biochem, Inc.
Industry: Medical - Biomedical and Genetics
Company: Enzo Biochem, Inc.
Industry: Medical - Biomedical and Genetics
We are initiating coverage on ENZ shares with a BUY rating and 12-18 month price target of $7.50 per share
Provider: DAWSON JAMES SECURITIES, INC.
Analyst: WASSERMAN R
Company: Enzo Biochem, Inc.
Industry: Medical - Biomedical and Genetics
We are terminating coverage due to the departure from the firm of the prior covering analyst
Provider: RODMAN & RENSHAW, CO.
Company: Enzo Biochem, Inc.
Industry: Medical - Biomedical and Genetics
We are under review due to the departure from the firm of analyst
Provider: RODMAN & RENSHAW, CO.
Company: Enzo Biochem, Inc.
Industry: Medical - Biomedical and Genetics
We are under review due to the departure from the firm of analyst
Provider: RODMAN & RENSHAW, CO.
Company: Enzo Biochem, Inc.
Industry: Medical - Biomedical and Genetics
Selloff Overdone Now Trading at Just 0.5 EV-to-Sales Reiterating Outperform.
Provider: RODMAN & RENSHAW, CO.
Analyst: NOCHOMOVITZ Y
Company: Enzo Biochem, Inc.
Industry: Medical - Biomedical and Genetics
Selloff Overdone Now Trading at Just 0.5 EV-to-Sales Reiterating Outperform.
Provider: RODMAN & RENSHAW, CO.
Analyst: NOCHOMOVITZ Y
Company: Enzo Biochem, Inc.
Industry: Medical - Biomedical and Genetics
MORNING SUMMARY
Provider: RODMAN & RENSHAW, CO.
Company: Enzo Biochem, Inc.
Industry: Medical - Biomedical and Genetics
Lab Revenues Rise Steadily - Industry Multiples Compress - Lowering Target
Provider: RODMAN & RENSHAW, CO.
Analyst: NOCHOMOVITZ Y
Company: Enzo Biochem, Inc.
Industry: Medical - Biomedical and Genetics
Lab Revenues Rise Steadily - Industry Multiples Compress - Lowering Target
Provider: RODMAN & RENSHAW, CO.
Analyst: NOCHOMOVITZ Y
Company: Enzo Biochem, Inc.
Industry: Medical - Biomedical and Genetics
MORNING SUMMARY
Provider: RODMAN & RENSHAW, CO.
Company: Enzo Biochem, Inc.
Industry: Medical - Biomedical and Genetics
Updates from Meeting with Enzo Biochem Management at Rodman & Renshaw Conference
Provider: RODMAN & RENSHAW, CO.
Analyst: NOCHOMOVITZ Y
Company: Enzo Biochem, Inc.
Industry: Medical - Biomedical and Genetics
Updates from Meeting with Enzo Biochem Management at Rodman & Renshaw Conference
Provider: RODMAN & RENSHAW, CO.
Analyst: NOCHOMOVITZ Y
Company: Enzo Biochem, Inc.
Industry: Medical - Biomedical and Genetics
MORNING SUMMARY
Provider: RODMAN & RENSHAW, CO.
Company: Enzo Biochem, Inc.
Industry: Medical - Biomedical and Genetics
Potential Peptide Therapy for Bone Disorders Supports Long-Term Biotech Upside
Provider: RODMAN & RENSHAW, CO.
Analyst: NOCHOMOVITZ Y
Company: Enzo Biochem, Inc.
Industry: Medical - Biomedical and Genetics
Potential Peptide Therapy for Bone Disorders Supports Long-Term Biotech Upside
Provider: RODMAN & RENSHAW, CO.
Analyst: NOCHOMOVITZ Y
Company: Enzo Biochem, Inc.
Industry: Medical - Biomedical and Genetics
MORNING SUMMARY
Provider: RODMAN & RENSHAW, CO.